化学
生物信息学
对接(动物)
药代动力学
计算生物学
激酶
药理学
生物化学
医学
生物
基因
护理部
作者
Srichandan Padhi,Marco Masi,Yugal Kishore Mohanta,Muthupandian Saravanan,Swati Sharma,Alessio Cimmino,Dhivya Shanmugarajan,Antonio Evidente,Kumananda Tayung,Amit Kumar
标识
DOI:10.1016/j.molstruc.2022.134390
摘要
• Endolichenic fungal metabolites are potential inhibitors of glycolytic kinases • Three metabolites demonstrated quality binding against glycolytic kinases • Terricollene A-kinase complexes were structurally compact and stable • Glycoside ring and allyl group were important component in their interaction • Terricollene A can be a novel and effective inhibitor of glycolytic kinases Herein, Seventy three (73) anticancer metabolites from different endolichenic fungi which are reported previously, were analyzed for drug likeliness and pharmacokinetic properties using SwissADME, ADMETlab, and admetSAR. The desirable compounds were studied using molecular docking against three clinically important human kinases: pyruvate kinase isoform 2, hexokinase II, and phosphoglycerate kinase. The results displayed a significant binding affinity of the test ligands against the kinases compared to 3-bromopyruvic acid, a reference glycolytic inhibitor. Pharmacokinetics and binding interactions of three compounds including talaromycin A, pyridoxatin, and terricollene A were predicted to be substantial. Terricollene A bound complexes were found to have the most considerable binding free energies and therefore were investigated for their conformational stability and compactness under explicit water conditions using molecular dynamics simulation up to 100 ns. The residual decomposition of binding energies for each of the complexes was calculated using Molecular Mechanics Poisson–Boltzmann Surface Area (MM-PBSA) method. The results demonstrated substantial stability and compactness of terricollene A-kinase complexes. The findings will facilitate the development of potential glycolytic inhibitors for treating and controlling several forms of cancer; however, supplementary experimental investigations to evaluate the efficacy of the test ligand are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI